(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1375079

欧州のドラッグデリバリー市場：2028年までの予測-地域別分析-投与経路、流通チャネル、エンドユーザー別

Europe Drug Delivery Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Route of Administration, Distribution Channel, and End User
PrevNext
1
2
3
4

出版日
ページ情報
英文 247 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
欧州のドラッグデリバリー市場：2028年までの予測-地域別分析-投与経路、流通チャネル、エンドユーザー別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 247 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州ドラッグデリバリー市場は、2023年の6,322億6,846万米ドルから2028年には8,953億3,887万米ドルに成長すると予測されています。2023年から2028年までのCAGRは7.2%と推定されます。

非侵襲ドラッグデリバリーシステムに対する需要の高まりが欧州ドラッグデリバリー市場を後押し

非侵襲ドラッグデリバリーとは、一般に粘膜表面や皮膚の生物学的障壁を越えて痛みを伴わずに薬物を送達する方法を指します。このドラッグデリバリーによって、医薬品へのアクセスが改善され、治療方針の遵守が向上し、医薬品の安全性が向上する可能性があります。注射による薬物投与に比べ、このような明らかな利点があるため、患者は非侵襲的ドラッグデリバリー経路を好みます。非侵襲的な方法で薬物を投与すると、処置中の痛みが軽減されるため、患者のコンプライアンスが非常に高くなることがわかっています。医療機器や経皮デリバリー技術の向上により、非侵襲的な薬物送達方法は、経口や注射による従来の薬物送達方法と競合する準備が整いつつあります。外用薬、経皮活性薬（デバイスによる浸透促進）、経皮受動薬、経眼膜薬、経粘膜薬、吸入薬からの肺胞膜を介したデリバリーなどは、よく使われる非侵襲的ドラッグデリバリー法の一部です。

拒絶率の低さ、投与の容易さ、利便性、耐久性から、TDDSはドラッグデリバリーの最も魅力的な方法となっています。医療施設での薬剤投与に加え、TDDSはスキンケア業界におけるさまざまな処置にも使用できます。この方法では主に局所投与が行われるため、薬剤が標的としない組織への非特異的デリバリーを防ぐことができます。TDDSの開発は、心血管・中枢神経系疾患、遺伝性疾患、糖尿病、神経筋疾患、感染症（局所を含む）の蔓延を抑制するのに役立つ可能性が高く、同時にワクチン接種の進歩や、長期治療のための薬剤の自己投与に対する患者の嗜好を促進します。

非侵襲的な方法によるドラッグデリバリーは、投与回数を減らし、投与スケジュールを簡略化します。さらに、これらのデリバリーシステムは、患者がこれらの方法で薬剤を自己投与できるため、臨床使用コストを大幅に削減することができます。多くの場合、非侵襲的デリバリーシステムを用いたドラッグの製造コストは、注射の製造コストよりも低いです。例えば、吸入インスリンは、糖尿病治療のための忍容性が高く、好まれる方法として登場しました。このように、非侵襲的ドラッグデリバリーシステムに対する需要の高まりが、ドラッグデリバリーシステム市場の成長を後押ししています。

欧州ドラッグデリバリー市場概要

欧州ドラッグデリバリー市場は、ドイツ、フランス、イタリア、英国、スペイン、その他の欧州に細分化されます。この地域の市場成長は、慢性疾患の増加、高齢者人口の増加、市場参入企業の拡大戦略、製薬産業の成長に関連しています。ドイツは技術の進歩で知られ、医療医療分野の最前線をリードしています。Haselmeier社などのドイツ企業は、D-Flexペンを開発しました。D-Flexペンは、以前に開発された注射ペンよりも効率的に機能するドラッグデリバリー機器です。このペンは、皮下自己注射用の次世代ドラッグデリバリーデバイスです。このマルチ用量固定ペンは、1回の固定用量またはあらかじめ設定された複数の用量で薬剤を投与することができるため、従来のドラッグデリバリーデバイスよりも好まれています。

欧州ドラッグデリバリー市場の収益と2028年までの予測（100万米ドル）

ドラッグデリバリーの欧州市場セグメンテーション

欧州ドラッグデリバリー市場は、投与経路、流通チャネル、エンドユーザー、国別に区分されます。

投与経路に基づき、欧州ドラッグデリバリー市場は、注射薬デリバリー、経口薬デリバリー、経粘膜薬デリバリー、局所薬デリバリー、移植薬デリバリー、眼薬デリバリーに区分されます。2023年の欧州ドラッグデリバリー市場では、注射薬デリバリー分野が大きなシェアを占めています。

流通チャネルに基づき、欧州ドラッグデリバリー市場は病院薬局、小売薬局、オンライン薬局に区分されます。病院薬局セグメントは2023年に欧州ドラッグデリバリー市場で最大のシェアを占めました。

エンドユーザー別に見ると、欧州のドラッグデリバリー市場は病院・クリニック、在宅医療現場、その他のエンドユーザーに区分されます。病院・クリニックセグメントは2023年に欧州ドラッグデリバリー市場で最大のシェアを占めました。

国別では、欧州ドラッグデリバリー市場はドイツ、フランス、英国、イタリア、スペイン、その他の欧州に区分されます。2023年の欧州ドラッグデリバリー市場のシェアはドイツが独占。

Bausch Health Companies Inc、Baxter International Inc、Becton Dickinson and Co、Boehringer Ingelheim International GmbH、Boston Scientific Corp、Gerresheimer AG、GlaxoSmithKline Plc、Johnson &Johnson、Novartis AG、Novo Nordisk AS、Pfizer Inc、Sever Pharma Solutionsが欧州ドラッグデリバリー市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 欧州ドラッグデリバリー市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州ドラッグデリバリー市場情勢

  • 概観
  • 欧州PEST分析
  • 専門家の見解

第5章 欧州ドラッグデリバリー市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の増加
    • 非侵襲ドラッグデリバリーシステムに対する需要の高まり
    • 製薬会社における研究開発費の増加
  • 主な市場抑制要因
    • ドラッグデリバリーシステムの開発に伴う高コスト
    • ドラッグデリバリーシステムにおける製品リコール
  • 主な市場機会
    • 患者のコンプライアンス向上への注力
  • 今後の動向
    • 戦略的開発と製品上市
  • 影響分析

第6章 ドラッグデリバリー市場-欧州分析

  • 欧州ドラッグデリバリー市場収益と予測分析

第7章 欧州ドラッグデリバリー市場：2028年までの収益と予測：投与経路別

  • イントロダクション
  • 欧州ドラッグデリバリー市場の投与経路別収益シェア（2022年、2028年）
  • 注射ドラッグデリバリー
  • 経口ドラッグデリバリー
  • 局所ドラッグデリバリー
  • 経粘膜ドラッグデリバリー
  • 埋め込み型ドラッグデリバリー
  • 眼科用ドラッグデリバリー

第8章 欧州ドラッグデリバリー市場：2028年までの収益と予測：流通チャネル別

  • イントロダクション
  • 欧州ドラッグデリバリーシステム市場の流通チャネル別収益シェア（2022年、2028年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 欧州ドラッグデリバリー市場：2028年までの収益と予測：エンドユーザー別

  • イントロダクション
  • 欧州ドラッグデリバリーシステム市場のエンドユーザー別売上高シェア（2022年、2028年）
  • 病院およびクリニック
  • 在宅医療の現場
  • その他のエンドユーザー

第10章 欧州ドラッグデリバリー市場：2028年までの収益と予測：国別分析

  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州

第11章 欧州ドラッグデリバリー市場：業界情勢

  • イントロダクション
  • 欧州ドラッグデリバリー市場の成長戦略
  • 有機的成長戦略
  • 概要
  • 無機的成長戦略
  • 概要

第12章 企業プロファイル

  • Becton Dickinson and Co
  • Novo Nordisk AS
  • Boston Scientific Corp
  • Baxter International Inc
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Bausch Health Companies Inc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Sever Pharma Solutions
  • Johnson & Johnson
  • Pfizer Inc

第13章 付録

図表

List Of Tables

  • Table 1. UK: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. UK: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. UK: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. UK: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. UK: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. UK: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UK: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Germany: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Germany: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Germany: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Germany: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Germany: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Germany: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Germany: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. France: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. France: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. France: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. France: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. France: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Spain: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Spain: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Spain: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Spain: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Spain: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Italy: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Italy: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Italy: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Italy: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Italy: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Italy: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Italy: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Italy: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Rest of Europe: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Recent Organic Growth Strategies in Europe Drug Delivery Market
  • Table 50. Recent Inorganic Growth Strategies in the Europe Drug Delivery Market
  • Table 51. Glossary of Terms, Europe Drug delivery market

List Of Figures

  • Figure 1. Europe Drug Delivery Market Segmentation
  • Figure 2. Europe Drug Delivery Market by Country
  • Figure 3. Europe Drug Delivery Market Overview
  • Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Europe Drug Delivery Market
  • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Europe Drug Delivery Market Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
  • Figure 11. Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pulmonary Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
  • Figure 35. Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Europe Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
  • Figure 39. Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Europe Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 43. Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
  • Figure 44. UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Growth Strategies in Europe Drug Delivery Market
目次
Product Code: BMIRE00028754

The Europe drug delivery market is expected to grow from US$ 6,32,268.46 million in 2023 to US$ 8,95,338.87 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2023 to 2028.

Growing Demand for Noninvasive Drug Delivery Systems Fuel Europe Drug Delivery Market

Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

Europe Drug Delivery Market Overview

The Europe drug delivery market is sub segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth in this region is associated with rise in incidences of chronic diseases, increase in the geriatric population, expansion strategies by the market players, and growth of the pharmaceutical industry. Germany is known for its technological advancements, leading the country to the forefront in the medical & healthcare sectors. German companies such as Haselmeier have developed the D-Flex pen, a drug delivery device that works more efficiently than previously developed injection pens. The pen is the next-generation drug delivery device for subcutaneous self-injection. The multi-dose fixed pen can administer the drug in a single fixed dose or several pre-set doses; therefore, it is preferred over conventional drug delivery devices.

Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

Europe Drug Delivery Market Segmentation

The Europe drug delivery market is segmented into route of administration, distribution channel, end user, and country.

Based on route of administration, the Europe drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Europe drug delivery market in 2023.

Based on distribution channel, the Europe drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Europe drug delivery market in 2023.

Based on end user, the Europe drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the Europe drug delivery market in 2023.

Based on country, the Europe drug delivery market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe drug delivery market in 2023.

Bausch Health Companies Inc; Baxter International Inc; Becton Dickinson and Co; Boehringer Ingelheim International GmbH; Boston Scientific Corp; Gerresheimer AG; GlaxoSmithKline Plc; Johnson & Johnson; Novartis AG; Novo Nordisk AS; Pfizer Inc; and Sever Pharma Solutions are the leading companies operating in the Europe drug delivery market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Drug Delivery Market - by Route of Administration
    • 1.3.2 Europe Drug Delivery Market - by Distribution Channel
    • 1.3.3 Europe Drug Delivery Market - by End User
    • 1.3.4 Europe Drug Delivery Market - by Country

2. Europe Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Drug Delivery Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
    • 5.2.2 Product Recalls in Drug Delivery Systems
  • 5.3 Key Market Opportunities
    • 5.3.1 Focus on Improving Patient Compliance
  • 5.4 Future Trends
    • 5.4.1 Strategic Developments and Product Launches
  • 5.5 Impact analysis

6. Drug Delivery Market -Europe Analysis

  • 6.1 Europe Drug Delivery Market Revenue Forecast and Analysis

7. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

  • 7.1 Overview
  • 7.2 Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
  • 7.3 Injectable Drug Delivery
    • 7.3.1 Overview
    • 7.3.2 Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Conventional Injection Devices
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.2 Advanced Devices
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Oral Drug Delivery
    • 7.4.1 Overview
    • 7.4.2 Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 Solid Oral Drugs
        • 7.4.2.1.1 Overview
        • 7.4.2.1.2 Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.2 Liquid Oral Drugs
        • 7.4.2.2.1 Overview
        • 7.4.2.2.2 Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.3 Semi-solid Oral Drugs
        • 7.4.2.3.1 Overview
        • 7.4.2.3.2 Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Topical Drug Delivery
    • 7.5.1 Overview
    • 7.5.2 Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.1 Semi-solid Topical Drug Delivery
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.2 Liquid Topical Drug Delivery Formulations
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.3 Solid Topical Drug Delivery Formulations
        • 7.5.2.3.1 Overview
        • 7.5.2.3.2 Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.4 Transdermal
        • 7.5.2.4.1 Overview
        • 7.5.2.4.2 Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Transmucosal Drug Delivery
    • 7.6.1 Overview
    • 7.6.2 Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 Pulmonary and Nasal Drug Delivery
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.2 Buccal and Sublingual Drug Delivery
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.3 Rectal Transmucosal Drug Delivery
        • 7.6.2.3.1 Overview
        • 7.6.2.3.2 Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.4 Vaginal Transmucosal Drug Delivery
        • 7.6.2.4.1 Overview
        • 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Implantable Drug Delivery
    • 7.7.1 Overview
    • 7.7.2 Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Ocular Drug Delivery
    • 7.8.1 Overview
    • 7.8.2 Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 Eye Drops and Sprays
        • 7.8.2.1.1 Overview
        • 7.8.2.1.2 Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.2 Gels and Ointments
        • 7.8.2.2.1 Overview
        • 7.8.2.2.2 Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.3 Ocular Inserts and Punctal Plugs
        • 7.8.2.3.1 Overview
        • 7.8.2.3.2 Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.4 Therapeutic Contact Lens
        • 7.8.2.4.1 Overview
        • 7.8.2.4.2 Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

  • 8.1 Overview
  • 8.2 Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By End User

  • 9.1 Overview
  • 9.2 Europe Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Other End User
    • 9.5.1 Overview
    • 9.5.2 Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 UK: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.1.3.1 UK: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.2 UK: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.3 UK: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.4 UK: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.5 UK: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.4 UK: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.1.5 UK: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Germany: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.2.3.1 Germany: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.2 Germany: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.3 Germany: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.4 Germany: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.5 Germany: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Germany: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.2.5 Germany: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 France: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.3.3.1 France: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.2 France: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.3 France: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.4 France: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.5 France: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.4 France: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.3.5 France: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Spain: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.4.3.1 Spain: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.4.3.2 Spain: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.4.3.3 Spain: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.4.3.4 Spain: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.4.3.5 Spain: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Spain: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.4.5 Spain: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Italy: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.5.3.1 Italy: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.5.3.2 Italy: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.5.3.3 Italy: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.5.3.4 Italy: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.5.3.5 Italy: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.5.4 Italy: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.5.5 Italy: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.6.3.1 Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.6.3.2 Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.6.3.3 Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.6.3.4 Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.6.3.5 Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Europe Drug Delivery Systems Market, by End User 2020-2028 (US$ Million)

11. Europe Drug Delivery Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Europe Drug Delivery Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Becton Dickinson and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novo Nordisk AS
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Baxter International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Gerresheimer AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 GlaxoSmithKline Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
      • 12.6.5.1 Key Developments
  • 12.7 Bausch Health Companies Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Boehringer Ingelheim International GmbH
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Novartis AG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Sever Pharma Solutions
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Johnson & Johnson
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Pfizer Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms